T attooing and body arts have become more prevalent in recent years, their popularity increasing among young adults. A population-based study revealed that one third of people younger than 30 years old in the United States have at least one tattoo. 1 Canadian data indicate that around 8% of high school students have at least one tattoo 2, 3 and that 21% of those who did not have a tattoo were eager to have one. Tattooing requires injection of pigments into the dermal layer of skin by repeated puncture of the skin. Such close contact of the tattoo instruments with blood and bodily fluids may cause transmission of viral and bacterial infections if the instruments are used on more than one person without being sterilized.
Selection criteria
Observational studies that assessed the association between tattooing and hepatitis B were included if they clearly defined: 1) hepatitis B as either primary or secondary outcome based on serology test, and 2) tattoos as either primary or secondary exposure; and presented relative risks or odds ratios (ORs) and their corresponding 95% confidence intervals (95% CI) or provided sufficient data to compute these parameters. If a study was published in different phases or data were duplicated in more than one publication, we only included the most recent. Two authors (SJ and SB) scanned the titles of abstracts identified through our search strategy and excluded articles that did not meet the selection criteria, such as those on basic sciences, review articles, letters to editor, and commentaries.
Data extraction
We created a spreadsheet and recorded study characteristics, including authors' names, publication year, country of study, study design, sample size, study population, mean age and/or range, gender of participants, type of risk factors or confounders adjusted for, outcome of interest (hepatitis B), and the adjusted OR and 95% CI. Included articles were reviewed in full by two independent reviewers (SJ and SB). All discrepancies were resolved after reviewing the source papers and further discussion among two reviewers. Studies were included only after full consensus was achieved. For studies that provided several levels of exposure, each exposure was categorized and analyzed in the designated subgroup.
Statistical analysis
We pooled the OR and 95% CI of all studies to calculate the overall risk. If a study provided more than one OR, we used the OR that was representative of all participants to calculate the overall pooled OR and 95% CI of all studies included in the meta-analysis. If the overall OR (95% CI) for all participants was not provided in a study, we calculated the pooled OR of that study and then used it for the purpose of calculation of overall OR (95% CI) of our meta-analysis. We performed several subgroup analyses to investigate the association between tattooing and risk of hepatitis B among different populations. We conducted subgroup analyses based on the study population and study design (case control, cohort, and cross-sectional). We grouped the studies on tattoos and hepatitis B into four main groups: 1) community sample (e.g., blood donors, students, and pregnant women), 2) hospital samples, 3) prisoners and 4) high-risk populations (street youth, persons with HIV, people who use drugs, those whose tattoos were done with reused tattoo needles, and those tattooed in non-professional tattoo parlours). Because only three studies in our review [W5,W18,W31]* were reporting samples derived from blood donors, we did not create a subgroup for this group; however, those studies are included in the pooled analysis. We calculated pooled OR (95% CI) from one study [W9] that provided data on both tattoos performed in non-professional parlours and tattoos done with reused needles, and used it in the subgroup of high-risk subjects.
For all analyses, we weighted the study-specific adjusted log ORs by the inverse of their variances. A random effects model was used to estimate the pooled adjusted OR. Statistical heterogeneity between studies was evaluated with Higgins I 2 statistic. 7 Sensitivity analysis was carried out to assess the influence of individual studies and then repeating the analysis by excluding the studies with the largest weights. Figure 1 shows the results of our search strategy and step-by-step inclusion and exclusion of the retrieved papers. We identified a total of 516 citations related to risk factors of hepatitis. After excluding 273 duplicates, 243 titles were reviewed, of which 64 were selected for abstract review; of these, 59 studies were selected for full-text review. The review process resulted in 31 studies (19 crosssectional, 9 case-control, 3 cohort), with a total of 665,169 participants from 19 countries, being included in the meta-analysis. All studies identified were in English. Characteristics of the 31 studies included in the meta-analysis are presented in Table 1 .
RESULTS
We found a statistically significant association (pooled OR=1. -Not enough data (8) -Mixed data for tattooing and scarification (2) -Mixed data for hep B and C (1) Figure 2 shows the results of our meta-analysis for association between tattooing and risk of hepatitis B for four main subgroups of samples derived from community, hospital, prison inmates, and high-risk groups.
We conducted a subgroup analysis to investigate the effect of the study design on the association of tattooing and the risk of hepatitis B. The association between tattooing and risk of hepatitis B was the strongest among case-control studies (OR=1.97, 95% CI: In studies of tattooing and hepatitis B, a moderate heterogeneity was detected (I 2 =47%) in this review. Using Jackknife method, 8 six studies [W1,W2,W3,W10,W12,W13] were identified to be the source of heterogeneity. Removing these studies from the analysis resulted in elimination of the heterogeneity from pooled and subgroup analysis. However, pre-and post-sensitivity overall pooled OR (95% CI) (pre-sensitivity OR=1.48, 95% CI: 1.30-1.68, I²=47%; post-sensitivity OR=1.58, 95% CI: 1.44-1.74, I²=0%), and pre-/postsensitivity OR (95% CI) in community samples (pre-sensitivity OR=1.47, 95% CI: 1.12-1.92, I²=58%; post-sensitivity OR=1.51, 95% CI: 1.25-1.84, I²=0%) and prisoners (pre-sensitivity OR=1.30, 95% CI: 1.01-1.66, I²=56%; post-sensitivity OR=1.62, 95% CI: 1.33-1.96, I²=0%) increased, whereas for hospital samples (pre-sensitivity OR=1.45, 95% CI: 1.07-1.97, I²=16%; post-sensitivity OR=1.35, 95% CI: 1.07-1.72, I²=0%), these diminished. Differences in the study populations, time and place that the studies were conducted and the study methodology would potentially contribute to the heterogeneity in this study. To further examine the effect of adjustment done in some studies, we removed studies with non-adjusted OR from all subgroups. We did not find any significant change in pooled OR (95% CI) (pre-sensitivity OR=1.48, 95% CI: 1.30-1.68, I²=47%; post-sensitivity OR=1.48, 95% CI: 1.24-1.77, I²=30%). We did not conduct such a sensitivity for subgroups because exclusion of studies with unadjusted OR resulted in a small number of studies in each subgroup.
DISCUSSION
Results of our systematic review indicate an increased risk of hepatitis B infection among those who receive tattoos. The risk is persistent among all population subgroups. Not surprisingly, the strongest association is observed among samples from the high-risk populations: injection drug users, sex workers, street youth, HIV patients, those whose tattoos were done with reused tattoo needles, and those tattooed in non-professional tattoo parlours.
A major strength of our review is the large number of studies and the multinational nature of the study sample. We found an association between tattooing and hepatitis B in all subgroups and across all study designs. Our findings are consistent with the literature which documents an association between tattooing and risk of transmission of other infections (including HIV, 9 leprosy, 10 tetanus, 9 and Methicillin Resistant Staphylococcus Aureus
11
) and with a systematic review of hepatitis C. 12 Several studies have indicated a dose-response relationship between tattooing and the risk of transmission of hepatitis C. [13] [14] [15] In fact, the risk of transmission of hepatitis C infection increases with the increase in the surface area covered by a tattoo as well as the number of tattoos received by an individual. Taking into account that the infectivity and inocula differ between HBV and HCV and considering that such doseresponse associations between tattooing and risk of transmission of hepatitis B were not reported in the included studies, this topic requires further study.
The risk from tattooing may depend on the background prevalence of hepatitis B infection and immunization uptake in the subgroups of a population. Tattooing among prisoners is an area of concern due to the high prevalence of hepatitis B infection among incarcerated individuals; the background rates of hepatitis B infection are 10 to 20 times higher among prisoners [16] [17] [18] than among the general public. Reusing and sharing tattoo needles are reported to be common practice among almost 45% of prisoners. 19 However, our results indicate that the association between tattooing and the risk of transmission of hepatitis B among prisoners is minimally lower compared with other subgroups. This may be because of variations in study design and sampling method among included studies or immunization programs within correctional facilities. The results of this study support the recommendations of experts, 19 advocating the need for prison programs that provide safer tattooing practices to inmates. Such programs may also prevent the transmission of other blood-borne infections among the prison population.
Given that hepatitis can spread through percutaneous or mucous membrane exposure to blood, 20 needlestick injury, 21 and tattooing using unsterile equipment, 22 several measures can be implemented to prevent the transmission of hepatitis B among tattoo recipients. Educational programs for tattoo parlour owners and tattoo artists which reinforce the guidelines and emphasize the importance of appropriate infection control measures should be implemented. These measures include the use of single-use sterile tattoo needles, proper functioning of autoclaves, use of appropriate disinfectants and keeping records of sterilization techniques. Regular and unscheduled inspection of tattoo parlours conducted by health protection units of the local health authorities may improve adherence to the current guidelines. Insufficient follow-up can cause public panic and has resulted in lawsuits against health authorities and business owners in Canada and the United States in recent years. 23 Tattoo parlours should be required to keep records of their clients and to report any adverse event related to tattooing to local health authorities.
12,22 Tattoo recipients should be provided with written handouts informing them about the risks related to tattooing and the signs and symptoms of common infections that can be transmitted through tattooing. Last, tattoo artists and clients should be aware of the availability of an effective vaccine for the prevention of hepatitis B infection.
Many countries have introduced a universal infant and/or adolescent hepatitis B immunization program; therefore those who undergo tattooing at a young age are now likely to be immunized. In Canada, all unimmunized individuals who are at increased risk of hepatitis B infection (i.e., IDU, persons with high-risk sexual behaviour) are recommended to receive hepatitis B vaccine. However, this strategy has several limitations. Risk factors cannot be identified for about 25% of acute hepatitis B infections, 24 Forest plot of meta-analysis of tattooing and risk of transmission of hepatitis B groups. 25 Therefore, it is important to ensure that individuals have been fully immunized -including those who move between jurisdictions which may have different immunization schedules -and to concentrate on immunization of high-risk and prison populations.
Over time, there has been a shift in the demographics of the people who acquire tattoos. Tattoos are no longer popular just among people with high-risk behaviour, but are becoming common among younger adults with a more conservative lifestyle. This increased prevalence of tattooing warrants the need for prevention programs that target young adults. 26 Our study is subject to several limitations due to the observational nature of the studies included in the review. Information on the past history of tattooing may not reflect the current population risk of hepatitis infection. Second, recall bias and social desirability bias may affect the validity of the information collected in observational studies. Finally, it is important to note that background prevalence of hepatitis B infection and hepatitis B vaccinations vary in different settings and countries. We did not have specific geographic data on the transmission of hepatitis B. Further studies to determine the pre-tattoo hepatitis B serostatus and the prevalence of other high-risk behaviours are needed to fully assess the association between tattooing and hepatitis B transmission.
The results of this systematic review are consistent with an increase in all population groups in the risk of contracting hepatitis B through tattooing. Immunization of susceptible individuals with hepatitis B vaccine, unscheduled inspection and enforcement of infection control guidelines in tattoo parlours, and provision of safe tattoo programs to inmates can play an important role in the interruption of transmission.
